Kathleen Borthwick
Fortune : 31 170 $ au 31/05/2026
Fortune : 31 170 $ au 31/05/2026
Kathleen Borthwick is currently Chief Financial Officer at Passage Bio, Inc. since 2024.
Formerly, Ms. Borthwick was Head-Business Development at Johnson & Johnson Services, Inc. Education includes an MBA from Tuck School of Business at Dartmouth and an undergraduate degree from The Wharton School of the University of Pennsylvania.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PASSAGE BIO, INC. 0,17 % | 16/03/2026 | 5 402 ( 0,17 % ) | 31 170 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PASSAGE BIO, INC. | Directeur Financier/CFO | 28/07/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Operates as medicine and health care products manufacturing company | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Operates as medicine and health care products manufacturing company | Health Technology |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national